SkyCell, a leader in pharma supply chain solutions, has invested significantly in Validaide, a Dutch digital platform for pharma lane risk management. This investment enhances Validaide’s position while maintaining its independence, serving over 1,600 companies globally. Validaide will continue to operate as a neutral partner for pharmaceutical firms and logistics providers. Planned enhancements include faster lane approvals, advanced risk modeling, improved compliance features, and emissions reporting to support sustainability goals, driving innovation and efficiency in the industry.

Source: https://www.stattimes.com/pharma/skycell-invests-millions-in-validade-becomes-major-shareholder-1354044